John Overdeck’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,800
| Closed | -$530K | – | 5200 |
|
|
2026
Q1 | $530K | Sell |
3,800
-1,300
| -25% | -$182K | ﹤0.01% | 3705 |
|
|
2025
Q4 | $626K | Buy |
+5,100
| New | +$620K | ﹤0.01% | 3194 |
|
|
2022
Q1 | – | Sell |
-89,000
| Closed | -$6.46M | – | 3295 |
|
|
2021
Q4 | $6.46M | Sell |
89,000
-78,200
| -47% | -$5.39M | 0.01% | 1044 |
|
|
2021
Q3 | $11.7M | Sell |
167,200
-11,000
| -6% | -$773K | 0.03% | 698 |
|
|
2021
Q2 | $12.3M | Sell |
178,200
-281,000
| -61% | -$18.8M | 0.03% | 693 |
|
|
2021
Q1 | $29.7M | Buy |
459,200
+367,600
| +401% | +$23.7M | 0.08% | 296 |
|
|
2020
Q4 | $5.34M | Sell |
91,600
-222,800
| -71% | -$13.4M | 0.02% | 895 |
|
|
2020
Q3 | $19.9M | Buy |
314,400
+232,400
| +283% | +$16.1M | 0.07% | 299 |
|
|
2020
Q2 | $6.31M | Buy |
82,000
+33,600
| +69% | +$2.58M | 0.03% | 555 |
|
|
2020
Q1 | $3.62M | Buy |
48,400
+11,900
| +33% | +$822K | 0.03% | 655 |
|
|
2019
Q4 | $2.37M | Sell |
36,500
-184,900
| -84% | -$12M | 0.01% | 1451 |
|
|
2019
Q3 | $14M | Buy |
221,400
+92,700
| +72% | +$6.06M | 0.05% | 447 |
|
|
2019
Q2 | $8.7M | Sell |
128,700
-130,400
| -50% | -$8.58M | 0.03% | 652 |
|
|
2019
Q1 | $16.8M | Buy |
259,100
+183,100
| +241% | +$12.2M | 0.05% | 454 |
|
|
2018
Q4 | $4.75M | Buy |
76,000
+56,000
| +280% | +$3.91M | 0.02% | 826 |
|
|
2018
Q3 | $1.54M | Sell |
20,000
-281,200
| -93% | -$21.2M | ﹤0.01% | 1661 |
|
|
2018
Q2 | $21.3M | Buy |
301,200
+221,600
| +278% | +$15.6M | 0.06% | 390 |
|
|
2018
Q1 | $6M | Buy |
79,600
+62,600
| +368% | +$4.98M | 0.02% | 851 |
|
|
2017
Q4 | $1.22M | Sell |
17,000
-38,000
| -69% | -$2.89M | ﹤0.01% | 1821 |
|
|
2017
Q3 | $4.46M | Sell |
55,000
-3,700
| -6% | -$283K | 0.02% | 865 |
|
|
2017
Q2 | $4.16M | Buy |
58,700
+41,400
| +239% | +$2.75M | 0.02% | 958 |
|
|
2017
Q1 | $1.18M | Sell |
17,300
-9,500
| -35% | -$668K | ﹤0.01% | 1816 |
|
|
2016
Q4 | $1.92M | Sell |
26,800
-27,000
| -50% | -$2.01M | 0.01% | 1519 |
|
|
2016
Q3 | $4.26M | Buy |
53,800
+30,800
| +134% | +$2.5M | 0.02% | 973 |
|
|
2016
Q2 | $1.92M | Sell |
23,000
-32,000
| -58% | -$2.84M | 0.01% | 1286 |
|
|
2016
Q1 | $5.05M | Buy |
55,000
+6,000
| +12% | +$541K | 0.02% | 706 |
|
|
2015
Q4 | $4.96M | Buy |
49,000
+41,000
| +513% | +$4.27M | 0.02% | 666 |
|
|
2015
Q3 | $786K | Buy |
8,000
+2,000
| +33% | +$222K | ﹤0.01% | 1325 |
|
|
2015
Q2 | $702K | Sell |
6,000
-4,000
| -40% | -$437K | ﹤0.01% | 1897 |
|
|
2015
Q1 | $981K | Buy |
+10,000
| New | +$1.02M | ﹤0.01% | 1596 |
|
Other funds holding GILD
John Overdeck's GILD Position: Q2 2026 in Review
John Overdeck increased its Gilead Sciences (GILD) stake by 2,931% in Q2 2026, buying an estimated $52.1M and bringing the position to 409,174 shares worth $51.7M. The position accounts for 0.04% of the portfolio, ranked #544.
John Overdeck first reported a position in GILD in Q2 2013 and has held it in 46 quarters since. The position peaked at $254M in Q4 2022. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- John Overdeck held 409,174 shares of Gilead Sciences worth $51.7M as of Q2 2026.
- John Overdeck bought 395,674 Gilead Sciences shares in Q2 2026, an estimated $52.1M.
- Gilead Sciences made up 0.04% of John Overdeck's portfolio in Q2 2026, its #544 holding.
- John Overdeck first reported a position in Gilead Sciences in Q2 2013 and has held it in 46 quarters since.
- John Overdeck's Gilead Sciences position peaked at $254M in Q4 2022.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.